tiprankstipranks
Trending News
More News >
Nls Pharmaceutics Ltd (NLSP)
:NLSP
US Market
Advertisement

NLS Pharmaceutics (NLSP) Income Statement

Compare
297 Followers

NLS Pharmaceutics Income Statement

Last quarter (Q2 2025), NLS Pharmaceutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, NLS Pharmaceutics's net income was $-2.22M. See NLS Pharmaceutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -3.32K$ -11.41K$ -11.41K$ -10.05K$ 0.00
Operating Expenses
$ 4.38M$ 11.81M$ 15.47M$ 11.85M$ 2.30M
Depreciation and Amortization
$ 3.32K$ 11.41K$ 11.41K$ 10.05K$ 0.00
EBITDA
$ -3.63M$ -11.80M$ -15.47M$ -11.85M$ -2.63M
Operating Income
$ -4.38M$ -11.81M$ -15.48M$ -11.86M$ -2.30M
Other Income/Expenses
$ 2.40M$ -364.97K$ -1.01M$ -85.46K$ -562.07K
Pretax Income
$ -1.98M$ -12.17M$ -16.50M$ -11.95M$ -2.86M
Net Income
$ -1.98M$ -12.17M$ -16.50M$ -11.95M$ -2.86M
Per Share Metrics
Basic EPS
$ -2.63$ -0.32$ -0.84$ -0.81$ -0.59
Diluted EPS
$ -2.63$ -0.32$ -0.84$ -0.81$ -0.59
Weighted Average Shares Outstanding
753.00K 38.18M 19.68M 14.75M 4.82M
Weighted Average Shares Outstanding (Diluted)
1.54M 38.18M 19.68M 14.75M 4.82M
Currency in USD

NLS Pharmaceutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis